Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-64.43	121.79	-342.43
Graham Fair Price	-61.30	0.34	0.87
PEG	-53.14	-2.58	-1.68
Price/Book	-19.17	0.88	1.09
Price/Cash Flow	35.57	62.29	45.94
Prices/Earnings	545.78	221.60	34.32
Price/Sales	-21.76	14.09	18.01
Price/FCF	35.57	62.29	45.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.05	0.93	0.89
Operating Margin	-91.13	< 0.005	0.09
ROA	-87.24	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-87.48
ROIC	< 0.005	< 0.005	-88.60
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.43	-0.84	49.15
Dividends QOQ	-0.98	-1.00	-1.98
EBIT QOQ	-0.38	-0.91	-140.77
EPS QOQ	-0.20	-0.86	-321.69
FCF QOQ	-0.29	-0.40	-38.59
Revenue QOQ	-0.23	0.03	-85.08
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	250.87	388.29	54.77
Days Sales Outstanding (DSO)	391.14	326.23	-16.59
Inventory Turnover	0.36	0.23	-35.39
Debt/Capitalization	< 0.005	< 0.005	-14.50
Quick Ratio	3.60	3.90	8.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.07	2.26	9.40
Cash	1.05	1.18	12.71
Capex	-0.01	-0.01	13.65
Free Cash Flow	0.05	0.03	-34.78
Revenue	0.13	0.14	13.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.70	4.05	9.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	289.70	-173.83	-40.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating